Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CINC - CinCor Pharma Inc

Previous close
29.06
0   0%

Share volume: 0
Last Updated: Thu 23 Feb 2023 06:00:00 AM CET
Medicinal and Botanical Manufacturing : -0.98%

PREVIOUS CLOSE
CHG
CHG%
$29.06
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
50%
Profitability 40%
Dept financing 18%
Liquidity 25%
Performance 75%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$29.06
P/E Ratio 
0.00
DAY RANGE
$29.02 - $29.35
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
43.764 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Marc de Garidel
Region: US
Website: https://www.cincor.com/
Employees: 21
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Medicinal and Botanical Manufacturing
Sector: Manufacturing

CinCor Pharma Inc. is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. The companys focus is on cardiovascular, metabolic and kidney diseases. CinCor Pharma was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in 2018.

Recent news